Kisspeptin 45-54, commonly referred to as Kisspeptin-10, is a synthetic 10-amino acid peptide corresponding to residues 45-54 of the native kisspeptin precursor protein. Despite its shorter sequence, laboratory studies indicate that it retains high affinity for the KISS1 (GPR54) receptor, making it a valuable research tool for investigating reproductive signaling, hypothalamic regulation, and neurobiology.
Current research utilizes Kisspeptin 45-54 in a variety of experimental models, including investigations of gonadotropin-releasing hormone (GnRH) signaling, ovarian steroidogenesis, hypothalamic neuronal communication, appetite regulation, and peptide interactions with protein aggregates associated with neurodegenerative diseases.
Kisspeptin 45-54 and Hypothalamic Signaling
Studies using immortalized hypothalamic neuron models suggest that Kisspeptin 45-54 influences gene expression within distinct hypothalamic regions involved in reproductive regulation.
Research has demonstrated increased expression of KISS1, enhanced neuronal activation markers such as c-Fos, and, in specific neuronal populations, elevated GnRH transcription following peptide exposure. These findings support its application in laboratory models investigating hypothalamic-pituitary-gonadal (HPG) axis signaling and neuroendocrine communication.
Research on the Gonadotropic Axis
Kisspeptin 45-54 is widely employed to examine mechanisms regulating reproductive hormone signaling.
Experimental studies indicate that the peptide stimulates GnRH release in a concentration-dependent manner and provides researchers with a useful model for evaluating interactions between kisspeptin neurons, neurokinin B (NKB), and downstream endocrine pathways.
Outside the central nervous system, laboratory investigations in ovarian granulosa cells have reported increased progesterone synthesis, elevated StAR gene expression, enhanced cholesterol availability, and reduced microRNA-1246 expression following peptide exposure, making Kisspeptin 45-54 valuable for steroidogenesis research.
Neurobiology and Protein Aggregate Research
Emerging laboratory evidence suggests that Kisspeptin 45-54 may interact directly with misfolded protein aggregates independently of the KISS1 receptor.
In neuronal cell culture models, researchers have observed reduced toxicity associated with amyloid-β peptides and α-synuclein protein aggregates, alongside improvements in mitochondrial integrity and decreased apoptotic signaling. Computational modeling further suggests stable peptide-protein interactions, supporting continued investigation into mechanisms involved in protein aggregation and neuronal cell survival.
Appetite Regulation and Metabolic Research
Kisspeptin 45-54 has also been investigated in hypothalamic models examining appetite-related signaling pathways.
Experimental findings indicate increased expression of neuropeptide Y (NPY) together with reduced brain-derived neurotrophic factor (BDNF) expression. Additional studies have reported alterations in dopamine and serotonin turnover, providing researchers with a model for exploring neurochemical pathways involved in energy balance, feeding behavior, and hypothalamic metabolism.
Research Applications
Due to its selective interaction with the KISS1 receptor and broad influence on neuroendocrine signaling, Kisspeptin 45-54 is frequently utilized in laboratory studies involving:
- Hypothalamic and GnRH signaling pathways
- Hypothalamic-pituitary-gonadal (HPG) axis research
- Reproductive endocrinology
- Ovarian steroidogenesis
- Neuroendocrine communication
- Appetite and metabolic signaling
- Protein aggregation and neurodegenerative disease models
- Cellular signaling and receptor biology
For laboratory research use only. Kisspeptin 45-54 is intended exclusively for scientific and preclinical investigation and is not intended for human or veterinary use.
